Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150
Research output: Contribution to journal › Article › peer-review
46Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150'. Together they form a unique fingerprint.